Childhood Leukemia: Most Common Childhood Cancer

submitted by: mdanderson

Childhood leukemia is the most common childhood cancer with more than 3,500 children in the U.S. diagnosed each year. Patrick Zweidler-McKay, M.D., Ph.D., Assistant Professor at The University of Texas MD Anderson Cancer Center Children’s Cancer Hospital, talks about symptoms, diagnoses and treatment of this blood disease. Zweidler-McKay also discusses health problems that may occur decades after treatment and encourages long term follow-up doctor visits.

Serious Adverse Events During Ruxolitinib Treatment Discontinuation in Patients with Myelofibrosis.

submitted by: mcgheekkm

Dr. Animesh Pardanani, Assistant Professor of Medicine and Consultant in the Division of Hematology at Mayo Clinic in Rochester, MN, Discusses his article, coauthored with Dr. Ayalew Tefferi, on potential complications from withdrawal of ruxolitinib. Available at:

Dr. Bernard Gersh discusses October 2009 Mayo Clinic Proceedings article on cell therapy for cardiac repair

submitted by: mcgheekkm

Dr. Bernard Gersh, Professor of Cardiology at Mayo Clinic, discusses his review "Cardiac Cell Repair Therapy: A Clinical Perspective" ( published in the October 2009 issue of Mayo Clinic Proceedings.

Rudolph Jaenisch Interview

submitted by: rsever

Stem cell expert Rudolph Jaenisch is interviewed by Richard Sever of Cold Spring Harbor Laboratory following his keynote lecture at the 2008 Cold Spring Harbor Symposium on Quantitative Biology

PJ Anne de Pagter (Transplant Reactivation Session)

submitted by: hhv-6foundation

"HHV-6 reactivation after stem cell transplantation: superior specific HHV-6 T cell responses are associated with poor clinical outcome"
6th International Conference on HHV-6 & 7 in Baltimore, Maryland, USA
Day 2 - June 21, 2008 - Transplant Reactivation Session